PASITHEA THERAPEUTICS CORP. Foreign Currency Transaction Gain, before Tax
PASITHEA THERAPEUTICS CORP. (KTTA) reported Foreign Currency Transaction Gain, before Tax of $30.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionGainBeforeTax · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. foreign currency transaction gain, before tax for the quarter ending 2026-06-30 was $30.00K.
- PASITHEA THERAPEUTICS CORP. foreign currency transaction gain, before tax for the quarter ending 2026-03-31 was $28.00K.
- PASITHEA THERAPEUTICS CORP. foreign currency transaction gain, before tax for the quarter ending 2025-12-31 was $1.00K.
- PASITHEA THERAPEUTICS CORP. foreign currency transaction gain, before tax for the quarter ending 2025-09-30 was $18.00K, a 33.33% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. foreign currency transaction gain, before tax for fiscal 2025 was $19.00K.
- PASITHEA THERAPEUTICS CORP. foreign currency transaction gain, before tax for fiscal 2024 was $0.00.
| Period end | Foreign Currency Transaction Gain, before Tax 3 month | Foreign Currency Transaction Gain, before Tax 3 month as first filed | Foreign Currency Transaction Gain, before Tax 6 month | Foreign Currency Transaction Gain, before Tax 6 month as first filed | Foreign Currency Transaction Gain, before Tax 9 month | Foreign Currency Transaction Gain, before Tax 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30.00K 10-Q · filed 2026-08-14 | $9.00K 10-Q · filed 2026-08-14 | $59.00K derived: sum of 3 quarters · filed 2026-08-14 | $77.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $28.00K 10-Q · filed 2026-05-15 | $29.00K derived: sum of 2 quarters · filed 2026-05-15 | $47.00K derived: sum of 3 quarters · filed 2026-05-15 | $47.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $19.00K derived: sum of 2 quarters · filed 2026-03-30 | $19.00K derived: sum of 3 quarters · filed 2026-08-14 | $19.00K 10-K · filed 2026-03-30 | ||
| 2025-09-30 | $18.00K 10-Q · filed 2025-11-13 | $18.00K derived: sum of 2 quarters · filed 2026-08-14 | $18.00K 10-Q · filed 2025-11-13 | -$13.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-14 | $29.29K 10-Q · filed 2025-08-14 | $0.00 10-Q · filed 2026-08-14 | $29.29K 10-Q · filed 2025-08-14 | -$31.00K derived: sum of 3 quarters · filed 2026-08-14 | -$4.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | -$31.00K derived: sum of 2 quarters · filed 2026-05-15 | -$4.00K derived: sum of 3 quarters · filed 2026-05-15 | |||
| 2024-12-31 | -$31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$4.00K derived: sum of 2 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $27.00K 10-Q · filed 2025-11-13 | $31.00K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |